Markets are Closed
Company Logo
BIIB
Biogen Inc.

Open

Previous Open

High

Previous High

Low

Previous Low

Close

Previous Close

Volume

Previous Volume

Company Profile

Description

Biogen Inc is a biopharmaceutical company. It is engaged in discovering, developing, manufacturing and delivering therapies to patients for the treatment of neurological, rare and autoimmune diseases.

Exchange

Nasdaq Global Select

List Date

January 03, 1994

CEO

Michel Vounatsos

Employees

7,300

Financials

Revenue

14.37B

Earnings

7.04B
14B
12B
9B
6B
4B
2015
2016
2017
2018

Splits

January 18, 20010.33%
December 21, 19990.50%

Dividends

No dividends paid to date

Related News

News post image: Novartis wins key European recommendation for gene therapy Zolgensma
Novartis wins key European recommendation for gene therapy Zolgensma
Mar 27, 2020 @ 14:20
Swiss drugmaker Novartis on Friday won a key European recommendation for its gene therapy Zolgensma against spinal muscular atrophy (SMA), clearing a hurdle for $2.1 million per patient treatment for approval in Europe within months. The European Medicines Agency's (EMA) Committee for Human Medicines...
finance yahoo
News post image: I Ran A Stock Scan For Earnings Growth And Biogen (NASDAQ:BIIB) Passed With Ease
I Ran A Stock Scan For Earnings Growth And Biogen (NASDAQ:BIIB) Passed With Ease
Mar 27, 2020 @ 10:18
Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of......
finance yahoo
News post image: 12 Key Medical Meetings Canceled Or Postponed In The Face Of A Pandemic
12 Key Medical Meetings Canceled Or Postponed In The Face Of A Pandemic
Mar 19, 2020 @ 14:51
Global events, meetings and symposiums are being canceled in droves as a precautionary measure to help contain the coronavirus pandemic. Biogen Inc (NASDAQ: BIIB) executives attended a conference sponsored by Cowen in Boston last month have become responsible for most cases of COVID-19 in Massachusetts...
finance yahoo
News post image: Coronavirus delays Biogen's Spinraza for some patients
Coronavirus delays Biogen's Spinraza for some patients
Mar 18, 2020 @ 23:44
U.S. drugmaker Biogen Inc said on Wednesday that some patients on its drug Spinraza - which treats a rare disorder called spinal muscular atrophy (SMA) - are having their treatments postponed to prioritize COVID-19 patients. Biogen did not give further details about how many patients were having their...
finance yahoo
News post image: Biogen Foundation Commits $10 Million to Support COVID-19 Relief Efforts in the U.S. and Around the World
Biogen Foundation Commits $10 Million to Support COVID-19 Relief Efforts in the U.S. and Around the World
Mar 16, 2020 @ 20:09
Biogen Inc. (BIIB) today announced that the Biogen Foundation has committed $10 million to support global response efforts and communities around the world impacted by the COVID-19 pandemic. The funds will be used to address immediate critical needs, with the majority of donations going to support non-profit...
finance yahoo
News post image: The Week Ahead In Biotech: COVID-19 Updates, Tapering Earnings Flow, Eton's Seizure Drug Review
The Week Ahead In Biotech: COVID-19 Updates, Tapering Earnings Flow, Eton's Seizure Drug Review
Mar 15, 2020 @ 13:55
The biopharma space bled along with the rest of the market and COVID-19 levered biotechs weren't spared either.Biogen Inc (NASDAQ: BIIB) was in the news for all wrong reasons, as an employee conference held by the company in Boston from Feb. 24 to 27 was blamed for 77 of the 95 COVID-19 cases reported...
finance yahoo
News post image: Boston hotel to close after outbreak at Biogen meeting
Boston hotel to close after outbreak at Biogen meeting
Mar 12, 2020 @ 16:22
The decision is based on "new information," Marriott International said in a statement Thursday....
finance yahoo
News post image: Massachusetts Virus Outbreak Looks Like Italy’s Just Two Weeks Ago
Massachusetts Virus Outbreak Looks Like Italy’s Just Two Weeks Ago
Mar 12, 2020 @ 14:48
(Bloomberg) -- At the Northeastern University Emergent Epidemics Lab, researchers have a convenient petri dish for studying the spread of pandemics: their hometown of Boston.The city is one of the major coronavirus clusters in the U.S., along with Westchester County, New York, and Seattle. In Boston,...
finance yahoo
News post image: The Zacks Analyst Blog Highlights: Amazon, IBM, Biogen, Newmont and Berkshire Hathaway
The Zacks Analyst Blog Highlights: Amazon, IBM, Biogen, Newmont and Berkshire Hathaway
Mar 12, 2020 @ 14:25
The Zacks Analyst Blog Highlights: Amazon, IBM, Biogen, Newmont and Berkshire Hathaway...
finance yahoo
News post image: Vir's stock gains 15% as it announces COVID-19 collaboration with Biogen
Vir's stock gains 15% as it announces COVID-19 collaboration with Biogen
Mar 12, 2020 @ 12:25
Shares of Vir Biotechnology Inc. gained 15% in premarket trading on Thursday after it said it intends to partner with Biogen Inc. to help develop and manufacture its monoclonal antibodies as a potential treatment of COVID-19. Biogen will handle clinical manufacturing of Vir's antibodies, the company said. Biogen's stock is down 3%. Vir, a startup biotechnology company founded in 2016, had previously announced plans to collaborate with Shanghai-based WuXi Biologics to test the antibodies as a treatment for the novel coronavirus. Vir CEO George Scangos previously was the chief executive of Biogen, which is facing COVID-19 cases of its own, after a cluster of infections emerged from a management meeting it held at a hotel in Boston in late February. All of its employees are working from home, as a result. Year-to-date, Vir's stock is up 168%, while shares of Biogen are down 0.8%. The S&P 500 is down 15% year-to-date....
finance yahoo